1 Introduction to Research & Analysis Reports
1.1 CAS9 Technology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAS9 Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAS9 Technology Overall Market Size
2.1 Global CAS9 Technology Market Size: 2023 VS 2030
2.2 Global CAS9 Technology Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key CAS9 Technology Players in Global Market
3.2 Global Companies CAS9 Technology Product & Technology
4 CAS9 Technology Companies Profiles
4.1 Cellecta Inc.
4.1.1 Cellecta Inc. Company Summary
4.1.2 Cellecta Inc. Business Overview
4.1.3 Cellecta Inc. CAS9 Technology Product Offerings & Technology
4.1.4 Cellecta Inc. CAS9 Technology R&D, and Plans
4.2 abm Inc.
4.2.1 abm Inc. Company Summary
4.2.2 abm Inc. Business Overview
4.2.3 abm Inc. CAS9 Technology Product Offerings & Technology
4.2.4 abm Inc. CAS9 Technology R&D, and Plans
4.3 GenScript
4.3.1 GenScript Company Summary
4.3.2 GenScript Business Overview
4.3.3 GenScript CAS9 Technology Product Offerings & Technology
4.3.4 GenScript CAS9 Technology R&D, and Plans
4.4 CRISPR Therapeutic
4.4.1 CRISPR Therapeutic Company Summary
4.4.2 CRISPR Therapeutic Business Overview
4.4.3 CRISPR Therapeutic CAS9 Technology Product Offerings & Technology
4.4.4 CRISPR Therapeutic CAS9 Technology R&D, and Plans
4.5 Intellia Therapeutics Inc.
4.5.1 Intellia Therapeutics Inc. Company Summary
4.5.2 Intellia Therapeutics Inc. Business Overview
4.5.3 Intellia Therapeutics Inc. CAS9 Technology Product Offerings & Technology
4.5.4 Intellia Therapeutics Inc. CAS9 Technology R&D, and Plans
4.6 GE Healthcare
4.6.1 GE Healthcare Company Summary
4.6.2 GE Healthcare Business Overview
4.6.3 GE Healthcare CAS9 Technology Product Offerings & Technology
4.6.4 GE Healthcare CAS9 Technology R&D, and Plans
4.7 Takara Bio Inc.
4.7.1 Takara Bio Inc. Company Summary
4.7.2 Takara Bio Inc. Business Overview
4.7.3 Takara Bio Inc. CAS9 Technology Product Offerings & Technology
4.7.4 Takara Bio Inc. CAS9 Technology R&D, and Plans
4.8 AstraZeneca
4.8.1 AstraZeneca Company Summary
4.8.2 AstraZeneca Business Overview
4.8.3 AstraZeneca CAS9 Technology Product Offerings & Technology
4.8.4 AstraZeneca CAS9 Technology R&D, and Plans
4.9 PLC
4.9.1 PLC Company Summary
4.9.2 PLC Business Overview
4.9.3 PLC CAS9 Technology Product Offerings & Technology
4.9.4 PLC CAS9 Technology R&D, and Plans
4.10 Merck KGaA
4.10.1 Merck KGaA Company Summary
4.10.2 Merck KGaA Business Overview
4.10.3 Merck KGaA CAS9 Technology Product Offerings & Technology
4.10.4 Merck KGaA CAS9 Technology R&D, and Plans
4.11 Bio-Rad Laboratories Inc.
4.11.1 Bio-Rad Laboratories Inc. Company Summary
4.11.2 Bio-Rad Laboratories Inc. Business Overview
4.11.3 Bio-Rad Laboratories Inc. CAS9 Technology Product Offerings & Technology
4.11.4 Bio-Rad Laboratories Inc. CAS9 Technology R&D, and Plans
4.12 Danaher Corporation (Integrated DNA Technologies Inc.)
4.12.1 Danaher Corporation (Integrated DNA Technologies Inc.) Company Summary
4.12.2 Danaher Corporation (Integrated DNA Technologies Inc.) Business Overview
4.12.3 Danaher Corporation (Integrated DNA Technologies Inc.) CAS9 Technology Product Offerings & Technology
4.12.4 Danaher Corporation (Integrated DNA Technologies Inc.) CAS9 Technology R&D, and Plans
4.13 New England Biolabs
4.13.1 New England Biolabs Company Summary
4.13.2 New England Biolabs Business Overview
4.13.3 New England Biolabs CAS9 Technology Product Offerings & Technology
4.13.4 New England Biolabs CAS9 Technology R&D, and Plans
4.14 OriGene Technologies Inc.
4.14.1 OriGene Technologies Inc. Company Summary
4.14.2 OriGene Technologies Inc. Business Overview
4.14.3 OriGene Technologies Inc. CAS9 Technology Product Offerings & Technology
4.14.4 OriGene Technologies Inc. CAS9 Technology R&D, and Plans
4.15 Lonza Group
4.15.1 Lonza Group Company Summary
4.15.2 Lonza Group Business Overview
4.15.3 Lonza Group CAS9 Technology Product Offerings & Technology
4.15.4 Lonza Group CAS9 Technology R&D, and Plans
4.16 Thermo Fisher Scientific
4.16.1 Thermo Fisher Scientific Company Summary
4.16.2 Thermo Fisher Scientific Business Overview
4.16.3 Thermo Fisher Scientific CAS9 Technology Product Offerings & Technology
4.16.4 Thermo Fisher Scientific CAS9 Technology R&D, and Plans
5 Sights by Region
5.1 By Region - Global CAS9 Technology Market Size, 2024 & 2030
5.2 By Region - Global CAS9 Technology Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of CAS9 Technology in United States
5.3.2 United States CAS9 Technology Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of CAS9 Technology in Europe
5.4.2 Europe CAS9 Technology Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of CAS9 Technology in China
5.5.2 China CAS9 Technology Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global CAS9 Technology Market Size Markets, 2024 & 2030
6.2 Genome Engineering
6.3 Disease Models
7 Sights by Application
7.1 By Application - Global CAS9 Technology Market Size, 2024 & 2030
7.2 Biotechnology & Pharmaceutical Companies
7.3 Academic & Research Institutes
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
